Market: median 1d +0.0% · breadth 39.9% advancing across 188 names
Data as of — announcements 2026-07-13 · flow 2026-07-08 · prices 2026-07-10
New today: CRS, CUV, DTR, NVU, RAP, RCM, REE, TM1. New names versus yesterday's letter, so a continuing story doesn't read as fresh news.
Read these (6)
Today's announcements worth minutes, not seconds — triaged by deterministic rules (a raise, a result into live flow, quantified materiality). The LLM annotates; it never picks the bucket.
CRS — Gold System Growth Continues Across Island Gold Project
Island Gold Project continues to validate a multi-lode system with consistent high-grade intercepts (15.4–124.7 g/t) across Vadrians, Baxter, Golconda, and newly identified mafic-hosted mineralization, expanding the exploration footprint. Re-sampling of hole 26IGRC010 (19 m @ 124.7 g/t) materially upgrades the previous composite interpretation, underlining grade confidence.
💰Best Vadrians intercept: 7.0 m @ 15.4 g/t Au · High-grade mafic hosted: 0.5 m @ 18.1 g/t Au · Re-sampled RC hole 26IGRC010: 19 m @ 124.7 g/t Au (1m splits) · Baxter extension: 7 m @ 10.0 g/t Au
Materiality: Drilling results support resource definition and extensional upside at a $72 m cap, but no maiden MRE or resource update disclosed; incremental exploration validation rather than near-term production catalyst.
Priced in? No material run-up over 20 days (+2%); market may be awaiting resource estimate or reserve calculations to reprice meaningfully.
SCENESSE® achieves its fourth major regulatory approval, completing North American + European authorization after two decades of clinical safety data (21,000+ doses). This validates the world's first systemic photoprotective drug for rare EPP and unlocks an established Canadian treatment network, though the ultra-rare disease footprint (~140k per capita) limits near-term revenue scale.
💰Regulatory milestone: Health Canada NOC approval for SCENESSE® (afamelanotide) in EPP · Market geography: 4th jurisdiction (Europe 2014, USA 2019, Australia 2020, Canada 2026) · Clinical safety profile: 21,000+ doses administered; up to 20 years continuous therapy · Target population: EPP: ~5,000–10,000 globally; ~1 in 140,000 in Canada
Materiality: Regulatory approval is strategically important but EPP is ultra-rare (~1 in 140k Canadians); Canadian market addition extends geographic reach and de-risks single-jurisdiction concentration, but incremental revenue contribution likely modest relative to $518m market cap absent near-term guidance.
Priced in? Stock +15% over 20d into approval; 0% movement in final 5d suggests market largely anticipated NOC outcome; no run-up immediately preceding announcement indicates pricing-in occurred gradually.
U.S. Department of Justice has backed DTR's Colosseum operations by opposing an NPCA lawsuit and affirming that the company's existing Plan of Operations remains valid and authorised under California Desert Protection Act. This removes a material regulatory overhang and validates the company's position to proceed with the BFS-sanctioned gold-rare-earth project.
Materiality: Regulatory approval removes legal risk to a $785m NPV project; favorable DOJ filing is material to project execution risk, though insufficient data on probability-weighted impact to quantify against $532m market cap.
Priced in? Stock +17% over 20d but -4% over 5d; DOJ filing represents new favourable legal development not obviously anticipated by market; timing suggests limited run-up into announcement.
NVU — 2nd-Phase ECS-DoT Drone Trials Deliver Gains of up to 51.0%
ECS-DoT drone autopilot optimization achieved 51% energy efficiency gains on complex flight paths representative of commercial operations, scaling gains with flight speed and path complexity. Results validate the technology's real-world applicability beyond Phase 1's simpler baseline, though testing remains confined to a single 2.8 kg airframe in controlled conditions.
💰Peak cruise efficiency gain: 51.0% at 7 m/s · Average efficiency gain: 48.5% at 7 m/s across all trajectories · Phase 1 baseline: 27.8% peak gain on simpler paths · System power consumption: <10 mW
Materiality: Product validation milestone with potential commercial drone market implications; insufficient data on revenue pipeline or addressable market to quantify against $48m market cap.
Priced in? Stock down 17% over 5d and 6% over 20d into announcement; result represents incremental validation (Phase 2 of trials) rather than unexpected breakthrough, suggesting modest upside already priced in by recent weakness.
RAP · $21M — Completed Chester Assays Expand Scale of Copper System
Chester drilling validates a stacked VMS system with broad, consistent copper intersections across three zones, but represents early-stage exploration with only ~28% of the 2.5km+ strike tested and upside contingent on resource growth. The copper grades (1–2.25%) are solid for VMS, though near-term value hinges on geological modelling and target refinement rather than imminent resource updates.
💰Best intercept (CDH015): 16.0m @ 1.26% Cu, incl. 5.0m @ 2.25% Cu · Existing MRE: 6.685Mt @ 1.07% Cu · Tested strike: ~700m of >2.5km interpreted system · Drill holes completed: 16 HQ holes, 2,126m total
Materiality: Drilling completion de-risks Chester geology on a small $21m market cap, but the existing MRE (6.7Mt @ 1.07% Cu) dwarfs the validation scope; resource growth material only if drilling extends beyond current estimate significantly.
Priced in? Stock down 8% over 5 days and 19% over 20 days into result; retail/institutional flows (+$5.8k inst., +$18.8k retail) modest and market maker net short (+$52.9k), suggesting limited anticipation and possible further weakness if result framed as validation-only.
RCM — Outstanding Silver Lead & Zinc Flotation Recoveries
Rougher flotation testwork confirms exceptional metallurgical response across silver, lead and zinc at Webbs and Consol, with industry-leading recoveries (98.7% Ag, 99.3% Pb) and high-grade concentrates de-risking a critical technical hurdle for project economics. Results validate commodity exposure and warrant progression to cleaner flotation and flowsheet optimization, though final saleable concentrate grades remain undefined.
Materiality: De-risks metallurgical technical risk for a $39m market-cap junior; recoveries of this magnitude materially improve project IRR/NPV outcomes if resource and engineering parameters support commercial viability—critical validation ahead of resource definition.
Priced in? Modest 6% run-up over 20d but -3% over 5d into release; metallurgical validation is expected at this stage but results exceeded typical benchmarks, suggesting some upside not yet fully priced.
Price-sensitive but routine — quarterlies and updates worth a headline-level pass.
DRE — RC and Diamond Drilling Commenced at Metzkes Find · quantified but moderate — skim
MGU — JACK LIFTON JOINS MAGNUM MINING · price-sensitive — skim
NPM — Trading Halt · quantified but moderate — skim
Broker tape — caveats
Who bought and sold, by broker cohort, on a T+3 lag — spikes vs each stock's own baseline, multi-session streaks, and warnings where 'buying' is likely someone absorbing an exit.